Alto Neuroscience Statistics

Total Valuation

ANRO has a market cap or net worth of $82.98 million. The enterprise value is -$38.51 million.

Market Cap	82.98M
Enterprise Value	-38.51M

Important Dates

The last earnings date was Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

ANRO has 27.07 million shares outstanding. The number of shares has increased by 106.95% in one year.

Current Share Class	27.07M
Shares Outstanding	27.07M
Shares Change (YoY)	+106.95%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	8.24%
Owned by Institutions (%)	56.91%
Float	17.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.69
P/TBV Ratio	0.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.43, with a Debt / Equity ratio of 0.20.

Current Ratio	18.43
Quick Ratio	18.16
Debt / Equity	0.20
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-51.08

Financial Efficiency

Return on equity (ROE) is -42.78% and return on invested capital (ROIC) is -26.01%.

Return on Equity (ROE)	-42.78%
Return on Assets (ROA)	-24.72%
Return on Invested Capital (ROIC)	-26.01%
Return on Capital Employed (ROCE)	-46.91%
Revenue Per Employee	n/a
Profits Per Employee	-$853,408
Employee Count	76
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.92% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-61.92%
50-Day Moving Average	2.67
200-Day Moving Average	3.22
Relative Strength Index (RSI)	64.50
Average Volume (20 Days)	118,823

Short Selling Information

The latest short interest is 2.15 million, so 7.93% of the outstanding shares have been sold short.

Short Interest	2.15M
Short Previous Month	2.01M
Short % of Shares Out	7.93%
Short % of Float	11.99%
Short Ratio (days to cover)	15.28

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-70.24M
Pretax Income	n/a
Net Income	-64.86M
EBITDA	-69.61M
EBIT	-70.24M
Earnings Per Share (EPS)	-$2.40

Full Income Statement

Balance Sheet

The company has $147.59 million in cash and $24.34 million in debt, giving a net cash position of $123.25 million or $4.55 per share.

Cash & Cash Equivalents	147.59M
Total Debt	24.34M
Net Cash	123.25M
Net Cash Per Share	$4.55
Equity (Book Value)	123.41M
Book Value Per Share	4.56
Working Capital	141.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$55.08 million and capital expenditures -$1.54 million, giving a free cash flow of -$56.62 million.

Operating Cash Flow	-55.08M
Capital Expenditures	-1.54M
Free Cash Flow	-56.62M
FCF Per Share	-$2.09

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ANRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-106.95%
Shareholder Yield	-106.95%
Earnings Yield	-76.54%
FCF Yield	-66.82%

Analyst Forecast

The average price target for ANRO is $10.40, which is 239.32% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.40
Price Target Difference	239.32%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1